JK

Julius Knowles

Partner, Mass General Brigham Ventures

Cambridge, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Drug Discovery
Biotechnology
Lifesciences
Pharmaceutical Industry
Technology Transfer
Commercialization
Oncology
Drug Development
Clinical Development
Biopharmaceuticals
R&D
Strategic Alliances

Education

Lists including Julius

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

MG
Mass General Brigham Ventures

2014

  • Partner

    2014

XB
X-BODY Biosciences

2012 - 2014

  • CEO

    2012 - 2014

    Acquired by Juno.

NP
Novartis Pharmaceuticals

2005 - 2012

  • Head, Platforms, Strategic Alliances

    2005 - 2012

Novalar Pharmaceuticals

2002 - 2005

  • President

    2002 - 2005

Novacea

2001 - 2002

  • Vice President, Business Development

    2001 - 2002

SGX Pharmaceuticals

1999 - 2001

  • Vice President, Business Development

    1999 - 2001

VP
Vertex Pharmaceuticals

1993 - 1999

  • Director, R&D Planning

    1993 - 1999